NovaScan Inc.
PrivateLast Round
Seed Round
Apr 28, 2026
Total Funding Raised
$12.74M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NovaScan Inc. operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Grant round in November 2025.
NovaScan Inc. is a diagnostic equipment company that has developed a platform for real-time cancer detection and stratification.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaScan Inc. Comparables
Compare NovaScan Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SurgiVance, Inc. | 82% | |
| Reveal Surgical | 81% | |
| Lumicell, Inc. | 79% |
For institutional investors. Book with your work email.
NovaScan Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 28, 2026 | ||||
| Grant | Nov 19, 2025 | ||||
| Series B | Nov 17, 2021 | ||||
| Early Funding | Sep 2, 2020 | ||||
| Early Funding | Jul 10, 2017 | ||||
Angel | Aug 15, 2006 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NovaScan Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stateline Angels | Series B |
| Gore Range Capital | Series B |
| Cancer Prevention & Research Institute of Texas | Grant |
| Builders VC | Series B |
| Harvard Business School Alumni Angels Chicago | Series B |
| Dipalo Ventures | Series B |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$671K raised in Seed Round.
- Apr 26, 2026
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
NovaScan Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NovaScan Inc.'s valuation, stock price, and market status.
Is NovaScan Inc. a public or private company?
NovaScan Inc. is a private company.
What is the current stock price of NovaScan Inc.?
NovaScan Inc. is a private company, so its shares have no public market price. Caplight tracks NovaScan Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovaScan Inc. worth (valuation)?
Valuation information for NovaScan Inc. is not publicly available.
Can I buy NovaScan Inc. stock?
NovaScan Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovaScan Inc.'s last funding round?
NovaScan Inc.'s most recent funding round was Seed Round on April 28, 2026.
Who are the main investors in NovaScan Inc.?
Key investors in NovaScan Inc. include Builders VC.
Will NovaScan Inc. IPO soon?
No public IPO plans have been announced for NovaScan Inc..
How can I track NovaScan Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NovaScan Inc.'s shares on secondary markets.